All | Cystic Fibrosis | Bronchiectasis | Other lung diseases* | |
---|---|---|---|---|
No. of patients | 676 | 279 | 239 | 158 |
Assessed for lung Tx | 218 | 66 | 8 | 144 |
Post lung Tx | 29 | 14 | 1 | 14 |
Mean age (years) | 47 | 28 | 63 | 56 |
Age range (years) | 2–91 | 2–77 | 9–91 | 13–72 |
% Male | 48 | 52 | 38 | 56 |
% Female | 52 | 48 | 62 | 44 |
No. of samples | 1002 | 405 | 323 | 274 |
Sputum | 969 | 401 | 312 | 256 |
BAL | 22 | 3 | 4 | 15 |
Bronchial secretions | 10 | 0 | 7 | 3 |
Tracheal aspirate | 1 | 1 | 0 | 0 |
*Patients (n = 158) with other lung diseases included those with the following conditions: | ||||
n | ||||
Chronic obstructive pulmonary disease | 51 | |||
Unspecified interstitial lung disease | 28 | |||
Idiopathic pulmonary fibrosis | 25 | |||
Fibrotic lung disease | 22 | |||
Pulmonary hypertension | 6 | |||
Sarcoidosis | 6 | |||
Nonspecific interstitial pneumonia | 5 | |||
Hypersensitivity pneumonitis | 4 | |||
Lymphangioleiomyomatosis (LAM) | 4 | |||
Complex congenital lung disease | 1 | |||
Graft versus host disease | 1 | |||
Histiocytosis X | 1 | |||
Langerhans cell histiocytosis | 1 | |||
Obliterative bronchiolitis | 1 | |||
Pleuroparenchymal fibroelastosis (PPFE) | 1 | |||
Progressive rheumatoid associated lung disease | 1 |